DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma

doi:10.3748/wjg.v20.i24.7894

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 24

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11539)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

695

WORD

256

HTML

8167

Figures (1-1)

198

Tables (1-3)

189

Sum=9505

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1139

Download

895

Sum=2034

Jun 28, 2014 (publication date) through Nov 18, 2024

Times Cited of This Article

Times Cited (69)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jun 28, 2014; 20(24): 7894-7913
Published online Jun 28, 2014. doi: 10.3748/wjg.v20.i24.7894

Full Size Figure Download Figure

Figure 1 Mature microRNAs silenced by aberrant DNA methylation and their affected target genes and pathways that are important in the development and progression of hepatocellular carcinoma. PI3K: Phosphatidylinositol-3-kinase; MAPK: Mitogen-activated protein kinase; EGF: Epidermal growth factor; PDGF: Platelet-derived growth factor; HGF: Hepatocyte growth factor; mTOR: Mammalian target of rapamycin; VEGF: Vascular endothelial growth factor; MMP: Matrix metalloproteinase; APC: Activated protein C; CTNNB1: Beta-catenin.

Citation: Anwar SL, Lehmann U. DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma. World J Gastroenterol 2014; 20(24): 7894-7913
URL: https://www.wjgnet.com/1007-9327/full/v20/i24/7894.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i24.7894